Atlantic Union Bankshares Corp
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 883948
GLEN ALLEN, VA
Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$59,001
-$22,391 QoQ
Shares Held
196
-20.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#622
of 786 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atlantic Union Bankshares Corp holds $10,486,437 across 45 Biotechnology names. ALNY ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14,182 | $7,044,623 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,186 | $2,610,138 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
3,343 | $182,327 | |
| 4 | TECH |
BIO-TECHNE Corp
|
1,100 | $77,715 | |
| 5 | OMER |
Omeros Corp
|
7,000 | $66,570 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
196 | $59,001 | |
| 7 | INCY |
Incyte Corp
|
500 | $56,680 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
2,500 | $44,925 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,001 | 196 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $81,392 | 246 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $91,856 | 231 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $87,096 | 191 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $30,000 | 92 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||